Evidence map›Paper›PMID 29966245›Full record

ArticleMolecules (Basel, Switzerland)2018

Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.

Wenrui Wang, Tiantian Chen, Henan Xu, Baihui Ren, Xiaodan Cheng, Rongrong Qi, Haibo Liu, Yueyue Wang, Lei Yan, Sulian Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Wenrui WangDepartment of Biotechnology, Bengbu Medical College, Bengbu 233030, China. wenrui-wang1983@163.com.
Tiantian ChenAnHui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu 233030, China. ttctoyy@gmail.com.
Henan XuAnHui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu 233030, China. z0170615@163.com.
Baihui RenDepartment of Biotechnology, Bengbu Medical College, Bengbu 233030, China. 18895689061@163.com.
Xiaodan ChengDepartment of Biotechnology, Bengbu Medical College, Bengbu 233030, China. 18895650868@163.com.
Rongrong QiDepartment of Biotechnology, Bengbu Medical College, Bengbu 233030, China. r18895640760@163.com.
Haibo LiuDepartment of Public Foundation, Bengbu Medical College, Bengbu 233030, China. haibo_liu1997@163.com.
Yueyue WangAnHui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu 233030, China. 18755295203@163.com.
Lei YanAnHui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu 233030, China. 13145520690@sina.cn.
Sulian ChenDepartment of Biochemistry and Molecular Biology, Bengbu Medical College, Bengbu 233030, China. csl9557@sina.com.
Qingling YangDepartment of Biochemistry and Molecular Biology, Bengbu Medical College, Bengbu 233030, China. yangqingling@bbmc.edu.cn.
Changjie ChenDepartment of Biochemistry and Molecular Biology, Bengbu Medical College, Bengbu 233030, China. tochenchangjie@163.com.
Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin (Cur) has been widely used in medicine, due to its antibacterial, anti-inflammatory, antioxidant, and antitumor effects. However, its clinic application is limited by its instability and poor solubility. In the present wok, curcumin was loaded into solid lipid nanoparticles (SLNs), in order to improve the therapeutic efficacy for breast cancer. The results measured using transmission electron microscopy (TEM) indicated that Cur-SLNs have a well-defined spherical shape; the size was about 40 nm with a negative surface charge. The drug loading and encapsulation efficiency in SLNs reached 23.38% and 72.47%, respectively. The Cur-SLNs showed a stronger cytotoxicity against SKBR3 cells. In vitro cellular uptake study demonstrated a high uptake efficiency of the Cur-SLNs by SKBR3 cells. Moreover, Cur-SLNs induced higher apoptosis in SKBR3 cells, compared to cells treated by free drug. In addition, Western blot analysis revealed that Cur-SLNs could promote the ratio of

Indexed as

LipidsNanoparticlesAntineoplastic AgentsApoptosisBiomarkersBreast NeoplasmsCell CycleCell Line, TumorCell MovementCell SurvivalCurcuminDrug CarriersDrug CompoundingFemaleHumansReactive Oxygen SpeciesAntineoplastic AgentsBiomarkersCurcuminDrug CarriersLipidsReactive Oxygen Speciesbreast cancercurcumincyclin D1solid lipid nanoparticle

Identifiers

PMID29966245
PMCPMC6099699
OpenAlexW2811214319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.